GLP-1 Pills vs Injections 2026: Wegovy Pill, Foundayo & Which Programs Offer Them

For years, starting a GLP-1 meant accepting a weekly injection. That stopped being true in December 2025, when the FDA approved the Wegovy pill (oral semaglutide), the first GLP-1 pill for weight management. Four months later, Foundayo (orforglipron) followed: a once-daily pill from Eli Lilly that, unlike oral semaglutide, can be taken any time of day with no food or water restrictions.

The 2026 oral GLP-1 lineup

Wegovy pill (oral semaglutide) · approved Dec 2025 · strict fasting protocol
Foundayo (orforglipron) · approved Apr 2026 · no food/water restrictions · from ~$149/mo self-pay

Pills vs injections: the honest trade-offs

Convenience: pills win for anyone needle-averse, but daily adherence replaces weekly. Oral semaglutide requires taking the pill on an empty stomach with minimal water, 30 minutes before food; orforglipron has no such restriction.
Effectiveness: injectables still hold the highest trial results (tirzepatide averaging roughly 20% body-weight reduction over 72 weeks alongside lifestyle changes). Oral options produce meaningful, somewhat lower averages. Which matters more, maximum effect or a form you’ll actually stick with, is a genuinely personal call.
Cost: the pill launches pushed prices down across the board. Foundayo’s $149/month entry price undercuts most brand-name injectables, and pressure from manufacturer-direct channels is dragging telehealth pricing with it.
Availability: oral options are newer and not every program carries them yet. Injectable semaglutide and tirzepatide, brand and 503A-compounded, remain the most widely offered.

How to find a program with the form you want

Across the 24 LegitScript-certified programs we review, medication lineups differ significantly: some offer both semaglutide and tirzepatide with the ability to switch under supervision, some carry oral options, and pricing runs from $69 to $249 per month. Our comparison table shows each program’s medications side by side, and the quiz factors in your form preference.

Frequently asked questions

What GLP-1 pills are available in 2026?

Two oral GLP-1 medications are FDA-approved for weight management: the Wegovy pill (oral semaglutide, approved December 2025) and Foundayo (orforglipron, approved April 2026). Both are once-daily.

How much do GLP-1 pills cost?

Foundayo launched at $149/month for the lowest dose self-pay, with insured patients potentially paying as little as $25/month with a savings card. Oral Wegovy pricing varies by channel and insurance. Telehealth programs offering oral options range widely; compare before committing.

Are GLP-1 pills as effective as injections?

Clinical data shows oral formulations produce meaningful weight loss, generally comparable to mid-range injectable dosing, alongside diet and exercise. Individual results vary; a licensed clinician can advise which fits your situation.

Can I get GLP-1 pills through telehealth?

Yes. Following the 2026 launches, oral GLP-1s are distributed through pharmacies and telehealth providers. A prescription after a medical evaluation is always required.

Match me to a program → Compare medications by program →

Educational content, not medical advice. Effectiveness figures reflect published clinical trials where medications were used alongside a reduced-calorie diet and exercise; individual results vary. All GLP-1 medications require a prescription from a licensed clinician. Consult a doctor about which medication and form is appropriate for you.

GLP-1 pills vs injections: what changed in 2026 and which programs offer what